Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”

Detalles Bibliográficos
Autores principales: Tran, Thi Ha Chau, Dumas, Stéphane, Coscas, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079526/
https://www.ncbi.nlm.nih.gov/pubmed/30116636
http://dx.doi.org/10.1155/2018/9171269
_version_ 1783345294718533632
author Tran, Thi Ha Chau
Dumas, Stéphane
Coscas, Florence
author_facet Tran, Thi Ha Chau
Dumas, Stéphane
Coscas, Florence
author_sort Tran, Thi Ha Chau
collection PubMed
description
format Online
Article
Text
id pubmed-6079526
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-60795262018-08-16 Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab” Tran, Thi Ha Chau Dumas, Stéphane Coscas, Florence J Ophthalmol Corrigendum Hindawi 2018-07-08 /pmc/articles/PMC6079526/ /pubmed/30116636 http://dx.doi.org/10.1155/2018/9171269 Text en Copyright © 2018 Thi Ha Chau Tran et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Corrigendum
Tran, Thi Ha Chau
Dumas, Stéphane
Coscas, Florence
Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”
title Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”
title_full Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”
title_fullStr Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”
title_full_unstemmed Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”
title_short Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”
title_sort corrigendum to “two-year outcome of aflibercept in patients with pigment epithelial detachment due to neovascular age-related macular degeneration (namd) refractory to ranibizumab”
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079526/
https://www.ncbi.nlm.nih.gov/pubmed/30116636
http://dx.doi.org/10.1155/2018/9171269
work_keys_str_mv AT tranthihachau corrigendumtotwoyearoutcomeofafliberceptinpatientswithpigmentepithelialdetachmentduetoneovascularagerelatedmaculardegenerationnamdrefractorytoranibizumab
AT dumasstephane corrigendumtotwoyearoutcomeofafliberceptinpatientswithpigmentepithelialdetachmentduetoneovascularagerelatedmaculardegenerationnamdrefractorytoranibizumab
AT coscasflorence corrigendumtotwoyearoutcomeofafliberceptinpatientswithpigmentepithelialdetachmentduetoneovascularagerelatedmaculardegenerationnamdrefractorytoranibizumab

Ejemplares similares